High raw material, int cost effect bottomline: Surya Pharma

Nov 4, 2009
 

posted a 21.3% surge in its net profit at Rs 19 crore versus Rs 15.7 crore for the second quarter in the financial year 2010 (Q2 FY10). The sales were up 58% at Rs 272.8 crore versus Rs 173 crore. In an interview with... [read full story]                    

powered by
Add Comment
View all news articles about*:
*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies